2025 CanHaem Annual Meeting: Improving Care Across the Hemoglobinopathies Spectrum

This year’s conference highlights the need to address not only severe forms of hemoglobin disorders like sickle cell anemia (HbSS) and beta thalassemia major, but also the often-overlooked milder forms such as hemoglobin SC, thalassemia intermedia, and alpha thalassemia. While research and treatments have made significant progress for the more severe forms, milder conditions are often left behind, with patients receiving less targeted care despite experiencing substantial symptoms that impact their quality of life. This gap in care reflects a disparity in focus, where advancements primarily benefit those with more severe forms. Expanding the conversation to include these less severe hemoglobinopathies ensures a more holistic approach, improving outcomes and quality of life for all individuals affected, not just those with the most critical cases.

Registration

Please note: A registration fee is required for this event. For additional details about the event and registration, including an online registration form, visit Home | 2025 CanHaem Annual Meeting